SCHEMBL20049857

SCHEMBL20049857

Bc1cnc(N(C)C(=C)C)c(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25583605 0.82 NOS3 (0.39) —
SCHEMBL25587712 0.73 GRIN2B (0.40) —
SCHEMBL25584224 0.71 GRIN2B (0.40) —
SCHEMBL25587614 0.71 GRIN2B (0.42) —
SCHEMBL20049966 0.70 GRIN2B (0.43) —
SCHEMBL25587000 0.70 GRIN2B (0.43) —
SCHEMBL20049785 0.70 GPBAR1 (0.39) —
SCHEMBL25584017 0.70 GRIN2B (0.40) —
SCHEMBL25584270 0.70 GRIN2B (0.43) —
SCHEMBL25587638 0.69 ESR2 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067786-A1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-12 — — WO disclosed
Send feedback